Top Story

AHA and ADA: CV risk assessment, monitoring essential for patients with type 1 diabetes

August 21, 2014

A greater understanding of the pathophysiology, risk prediction and treatment of CVD in patients with type 1 diabetes is essential to minimize the impact of these interrelated conditions, according to a new scientific statement from the American Heart Association and American Diabetes Association.

“CVD is a long-term complication of type 1 diabetes that is a major concern for patients and health care providers. … Despite the known higher risk of CVD in individuals with type 1 diabetes mellitus, the pathophysiology underlying the relationship between CV events, CVD risk factors and type 1 diabetes is not well understood,” the authors wrote in Diabetes Care.

figure FDA News

FDA opens dialogue on interim results of CV safety in diabetes drug trials

August 12, 2014
The FDA has launched a dialogue on how to handle confidentiality of the interim results for cardiovascular outcomes in diabetes treatment trials while new trials are…
In the Journals

Knowing modifiable risk factors may reduce CV death in type 2 diabetes

July 9, 2014
Determining vascular calcification and modifiable risk factors for heart disease could provide patients with type 2 diabetes the insight needed to take steps toward…
Meeting News Coverage

Higher obesity increases odds for cardiovascular, cancer, diabetes deaths

July 8, 2014
Adults with class III obesity are more likely to die from all causes than those within normal weight range, but particularly from heart disease, cancer and diabetes…

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »

Filter By:

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

Meeting News Coverage

ACC announces late-breaking clinical trials

January 31, 2014
The American College of Cardiology has announced the line-up of late-breaking clinical trials scheduled for presentation at its Annual Scientific…
In the Journals

Insulin-treated diabetes linked with mortality in TAVR

January 20, 2014
The mortality rate among patients with insulin-treated diabetes was approximately 15% higher than the rate for those without diabetes at follow-up of…
In the Journals

Patients with hyperglycemia, gene mutation exhibit low prevalence of vascular complications

January 15, 2014
Patients with a mutation in the gene encoding the enzyme glucokinase demonstrated a low prevalence for microvascular and macrovascular complications…
FDA approvals

FDA approves dapagliflozin for type 2 diabetes

January 8, 2014
The FDA has approved dapagliflozin (Farxiga, Bristol-Meyers Squibb and AstraZeneca), according to a press release. The approval includes a…
In the Journals

Mediterranean diet lowered diabetes incidence in older patients with high CV risk

January 7, 2014
Adhering to a Mediterranean diet high in extra-virgin olive oil intake reduced the risk for diabetes by 40% in patients at high risk due to…
In the Journals

Increased left atrial volume index predicted CV mortality in type 2 diabetes

December 30, 2013
Increased left atrial volume index was an independent and additional predictor of cardiovascular morbidity and mortality among patients with type 2…

Lipid Forum II Highlights

Heart disease remains No. 1 cause of death in US

December 20, 2013
Heart disease remains the No. 1 cause of death in United States and stroke remains the No. 4 cause of death, according to the American Heart…
In the Journals

Modest weight loss reduced CV risks in obese, middle-aged women

December 18, 2013
Modest 24-month weight loss improved risk factors for CVD and diabetes in middle-aged, overweight or obese women, according to findings in a new…
More Headlines »